0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Immune Disorders Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Interleukin 1 Beta Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Interleukin 1 Beta Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Complement C5 Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Complement C5 Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Chronic Rhinosinusitis With Nasal Polyps - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Rhinosinusitis With Nasal Polyps - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Autoimmune Hepatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Autoimmune Hepatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
EUR$1,500USDGBP
Acute Graft-versus-Host Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Acute Graft-versus-Host Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Chronic Spontaneous Urticaria- Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
EUR$2,000USDGBP
Chronic Rhinosinusitis - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Rhinosinusitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Crohn's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
EUR$3,000USDGBP
Chronic Otitis Media - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Otitis Media - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
Psoriasis - Pipeline Insight, 2025 - Product Thumbnail Image

Psoriasis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 100 Pages
  • Global
From
EUR$3,000USDGBP
Seborrhoeic Dermatitis - Pipeline Insight, 2025 - Product Thumbnail Image

Seborrhoeic Dermatitis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
EUR$1,250USDGBP
From
EUR$7,950USDGBP
From
EUR$3,950USDGBP
From
EUR$7,950USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
From
EUR$3,825USDGBP
EUR$4,500USDGBP
Loading Indicator

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection. The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more